Literature DB >> 201153

Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.

L Gergely, J Czeglédy, A Szalka, L Váczi, L Binder.   

Abstract

A method has been evolved for the demonstration of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infection in 83 cases of infectious mononucleosis. Serum samples were tested for EBV IgM, anti-VCA IgG, anti-EBNA, CMV IgM and CMV IgG antibodies. An acute-phase sample (or samples) and a convalescence sample were examined in each case, and in 44 cases an additional samples was examined 5-12 months after the illness. Since the different antibodies showed characteristic differences in both titre and persistence, a reliable serodiagnosis has become possible. Acute EBV infection is characterized by the presence of EBV-VCA IgG and EBV IgG antibodies and the lack of anti-EBNA. The latter becomes demonstrable as late as the 4th to 5th month after infection. Mean age of the patients was 19 years. EBV infection was demonstrated in 65%, CMV infection in 18% of the cases. In 12% double infection seemed to be probable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201153

Source DB:  PubMed          Journal:  Acta Microbiol Acad Sci Hung        ISSN: 0001-6187


  2 in total

1.  Antibodies to the second Epstein-Barr virus nuclear antigen in non-Hodgkin lymphomas.

Authors:  L Gergely; J Czeglédy; L Váczi; K Pálóczi; G Szegedi
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

2.  Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.

Authors:  L Gergely; J Gzeglédy; L Váczi
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.